Try the modernized ClinicalTrials.gov beta website. Learn more about the modernization effort.
Working…
ClinicalTrials.gov
ClinicalTrials.gov Menu

Prevalence Of Periodontitis Stage III & IV

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
 
ClinicalTrials.gov Identifier: NCT03779763
Recruitment Status : Completed
First Posted : December 19, 2018
Last Update Posted : July 15, 2020
Sponsor:
Information provided by (Responsible Party):
Omar Khaled Gamil Moussa Megahed, Cairo University

Brief Summary:
The study is a cross-sectional survey investigating the prevalence of Periodontitis stage III & IV in Egyptian dental patients attending the oral diagnosis clinic at faculty of Dentistry, Cairo University

Condition or disease
Periodontitis

Detailed Description:

Since the 1999 workshop, substantial new information has emergedfrom population studies, basic science investigations, and evidencefrom prospective studies evaluating environmental and systemic riskfactors. The analysis of this evidence has prompted the 2017 workshopto develop a new classification framework for periodontitis

In the last 30 years, the classification of periodontitis has been repeatedly upgraded in an attempt to align it with emerging scientific evidence. The workshop agreed that, consistent with current knowledge on pathophysiology, three forms of periodontitis can be identified: necrotizing periodontitis, periodontitis as a manifestation of systemic disease and the forms of the disease previously known as "chronic" or "aggressive", now grouped under a single category, "periodontitis".In revising the classification, the workshop agreed on a classification framework for periodontitis further characterized based on a multidimensional staging and grading system that could be adapted over time as new evidence emerges

Staging is largely dependent upon the severity of disease at presentationas well as on the complexity of disease management.While,grading provides supplemental information about biological features of the disease, including a history based analysis of the rate of disease progression, assessment of the risk for further progression, anticipated poor outcomes of treatment, and assessment of the risk that the disease or its treatment may negatively affect the general health of the patient

Staging involves four categories (stages 1 through 4) and is determined after considering several variables including clinical attachment loss, amount and percentage of bone loss, probing depth, presence and extent of angular bony defects, furcation involvement,tooth mobility and tooth loss due to periodontitis.

Stage III & IV are characterized by interdental clinical attatchment loss > 5mm and radiographic bone loss extending to the middle or apical third of the root. In stage III, four teeth or less are lost while in stage IV, five teeth or more are lost due to periodontitis. In addition to stage II complexity, Stage III is characterized by probing depth greater than or equal 6 mm, vertical bone loss greater than or equal 3mm, furcation involvement class II or III and moderate ridge defect. In addition to stage III complexity, stage IV is characterized by severe ridge defect , bite collapse, drifting and flaring.

The study aims at determining the prevalence of Periodontitis Stage III & IV in adult Egyptian dental outpatients attending the diagnostic centre at faculty of Dentistry, Cairo University

Layout table for study information
Study Type : Observational
Actual Enrollment : 750 participants
Observational Model: Ecologic or Community
Time Perspective: Cross-Sectional
Official Title: Prevalence Of Periodontitis Stage III &IV: A Hospital-Based Cross-Sectional Study On A Sample Of Adult Egyptian Dental Patients
Actual Study Start Date : June 15, 2019
Actual Primary Completion Date : June 15, 2019
Actual Study Completion Date : September 15, 2019

Resource links provided by the National Library of Medicine





Primary Outcome Measures :
  1. prevalence of Periodontitis stage III & IV [ Time Frame: after recriutment of required sample size , through study completion an average of one year ]


Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Layout table for eligibility information
Ages Eligible for Study:   15 Years and older   (Child, Adult, Older Adult)
Sexes Eligible for Study:   All
Sampling Method:   Probability Sample
Study Population
  • Dental patients will be recruited in a consecutive manner from the outpatient Diagnostic center, Faculty of Dentistry, Cairo University.
  • Medical history will be taken, thorough oral examination will be done, and a full questionnaire will be filled for each patient.
  • Before filling the questionnaire, the aim of the study will be explained to the patient and the patient's acceptance to participate in the survey will be received.
  • Non-respondent patients or patients refusing to participate will be reported with the cause of their refusal.
  • The questionnaire will be filled through a face-to-face personal interview with the patient using simple, short, easily comprehended questions.
  • The Questionnaire will include a section for demographic information of age, sex, social and educational levels of the patient. It will also include questions about medical condition, habits of trauma, smoking and its frequency.
Criteria

Inclusion Criteria:

  • Patients whose age is above 15 years old.
  • Patient consulting in the outpatient clinic
  • Provide informed consent.

Exclusion Criteria:

  • Patients having problem in opening their mouth or undergoing intermaxillary fixation where oral examination will not be possible.
  • Patients diagnosed with psychiatric problems or intoxicated with alcohol or drugs

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT03779763


Locations
Layout table for location information
Egypt
Faculty of Dentistry , Cairo Univeristy
Cairo, Egypt
Sponsors and Collaborators
Cairo University
Layout table for additonal information
Responsible Party: Omar Khaled Gamil Moussa Megahed, Master postgraduate student, Cairo University
ClinicalTrials.gov Identifier: NCT03779763    
Other Study ID Numbers: 21252461
First Posted: December 19, 2018    Key Record Dates
Last Update Posted: July 15, 2020
Last Verified: July 2019
Additional relevant MeSH terms:
Layout table for MeSH terms
Periodontitis
Periodontal Diseases
Mouth Diseases
Stomatognathic Diseases